Browse by ▼

Boston Scientific Corp.

  • What Are Insiders Buying These Days?

    By Meena Krishnamsetty - May 23, 2013 | Tickers: BBT, BSX, IBKC, X, WSR

    Studies show that stocks bought by insiders narrowly outperform the market (read our analysis of studies on insider trading) with our explanation for this finding being that company insiders have to be more confident than usual to buy the stock rather than diversify their wealth. Because the effect is not enormously large, as well as because of the fact that there are too many insider purchases for an investor to more »

  • Hedge Fund North Run Capital’s Top Q1 Stock Picks

    By Meena Krishnamsetty - May 21, 2013 | Tickers: AET, BSX, GM, HNT, HSP

    North Run Capital, run by its founders Todd Hammer and Thomas Ellis, recently filed their Q1 13F with the SEC, which describes some of their top equity holdings; we’ll look at the top five. See the original 13F here, and it’s important to note that quantitative analyses have revealed that individual investors can benefit by paying attention to hedge fund activity; discover the secrets of this strategy.

    Let more »

  • Insiders Are Buying These Stocks Now

    By Meena Krishnamsetty - May 20, 2013 | Tickers: BSX, CCC, ETFC, MUR, TSN

    We maintain a database of insider trading activity in order to track insider purchases. In theory, insiders should be very reluctant to purchase additional shares of their company and therefore increase company-specific risk; they should instead prefer to diversify their wealth unless they are particularly confident that the stock offers high expected returns. Therefore, observing an insider purchase should serve as a signal of that level of confidence, and in more »

  • Bright Outlook for Device Makers

    By Ted Cooper - April 28, 2013 | Tickers: BSX, MDT, STJ | Editor's Choice

    In my last article, I argued that Medtronic (NYSE: MDT), Boston Scientific (NYSE: BSX), and St. Jude Medical (NYSE: STJ) were potentially-attractive investments. However, I made a key assumption in the article that is undoubtedly false: I assumed that each company's operations will stay the exact same from now into eternity.

    Although the assumption is false, it is a useful starting point for further analysis. The goal of this more »

  • Obamacare Uncertainty Presents Opportunity

    By Ted Cooper - April 26, 2013 | Tickers: BSX, MDT, STJ

    Health care companies have been caught in a state of limbo since the passage of Obamacare. The market is still sorting out who wins and who loses from the landmark health care overhaul. Meanwhile, Congress has plans to repeal or amend parts of the law. All of this leads to uncertainty about these companies' futures. However, the market's indecisiveness poses as an opportunity for enterprising investors to scoop up more »

  • St. Jude Medical news raises investors’ heartbeat

    By Shas Dey - April 15, 2013 | Tickers: BSX, MDT, STJ

    Exciting news came out for St. Jude Medical (NYSE: STJ) shareholders as the company announced that its product, the AMPLATZER Cardiac Plug (ACP), was going into a key phase of clinical trial testing. The ACP is used for the prevention of stroke and the clinical trial is being conducted to demonstrate whether the ACP device is both able and safe to prevent blood clots from travelling out of the left more »

  • Buying the Boston Boom

    By Marshall Hargrave - April 14, 2013 | Tickers: ABT, BSX, MDT, STJ

    Boston Scientific (NYSE: BSX) has rallied nicely year to date, up over 35%, but is there still room to grow for this heart-related devices company? Cardiovascular disease remains the number one killer worldwide. The number of adults diagnosed with heart disease in the U.S. is around 11.8 percent of the total population. 
     
    Earlier this year Boston revised growth plans to better account for the challenging economic environment. Boston more »

  • Prem Watsa Is Buying Into This Small-Cap Stock, Should You Follow?

    By Anh HOANG - March 25, 2013 | Tickers: BSX, MDT, NVDQ

    Recently, Prem Watsa, who is well known as “Canada’s Warren Buffett”, increased his stake significantly in the Canadian medical imaging and therapeutic device company, Novadaq Technologies (NASDAQ: NVDQ). He first initiated a long position in the company in the fourth quarter of 2012, and then he added more in the middle of February, to own nearly 2.84 million shares in the company. Should we follow Prem Watsa into more »

  • Medtronics vs. Obamacare: A Fight to Remember

    By Kyle Dickinson - March 21, 2013 | Tickers: BSX, MDT

    I'm a college student. One day my professor began discussing the new 2.3% excise tax on medical devices caused by the Patient Protection and Affordability Care Act (otherwise known as Obamacare). Much to my surprise (and probably the professor's) the other students in the class were really engaged in the discussion. They were asking questions like, "Does the government have the power to impose this tax," and more »

  • Insider Buys in This Fast Growing but Loss Generating Company

    By Anh HOANG - March 18, 2013 | Tickers: BSX, DXCM, MDT

    Recently, Dr. Jay Skyler, a director of DexCom (NASDAQ: DXCM), spent nearly $1.1 million to buy 70,000 shares of the company at around $15.50 per share. Since Nov. 2011, DexCom’s share price has experienced a significant rise, from around $7 per share to $17 per share. Should investors be bullish about DexCom following its huge insider buy? Let’s find out.

    A glucose monitoring business

    DexCom more »

  • Are These 3 Stocks Survivors?

    By Gerelyn Terzo - March 13, 2013 | Tickers: BSX, JNJ, SYK

    May 2013 will mark the second annual National Mobility Awareness month. In preparation of the campaign, Jeff Probst, the host of "Survivor" and of his own talk show, "The Jeff Probst Show," handed a check worth $7,000 donated by the National Mobility Equipment Dealers Association to the recipient of a college scholarship. With mobility awareness on the horizon, I thought it would be a good time to evaluate some more »

  • America is Aging and These Stocks Will Benefit Handsomely

    By Robert Ciura - February 25, 2013 | Tickers: BAX, BSX, MDT

    It’s plainly evident that the United States is an aging society.  Baby Boomers are nearing retirement age in huge numbers.  According to the Department of Health and Human Service’s Administration of Aging (AoA), the older population--persons 65 years or older--numbered 39.6 million in 2009 (the latest year for which data is available). They represented 12.9% of the U.S. population, about one in every eight Americans more »

  • Intuitive Investors Should Invest in Intuitive Surgical

    By Leo Sun - February 13, 2013 | Tickers: BSX, ISRG, MAKO

    Intuitive Surgical (NASDAQ: ISRG) is one of the great growth stocks of this new millenium, rising over 4,700% in the past ten years. Although its days of such monstrous returns are over, the Sunnyvale, California-based medical equipment maker is still poised for incredible growth in the next decade. In this article, let’s analyze what makes this manufacturer of futuristic surgical machinery tick.

    From the Starship Enterprise’s sickbay more »

  • Should Investors Give Their Heart To This Company?

    By sayar bachhawat - January 23, 2013 | Tickers: BSX, MDT, STJ

    The other day, my neighbor had a sudden heart attack and was rushed to the hospital. He underwent treatment and came back home with a stent in his artery. I noticed that he wasn’t alone, and that heart ailments and diseases are a common occurrence affecting almost every US household. As an investor, it made me think of the companies that are manufacturing such devices used for medical treatment more »

  • Reasons To Be Optimistic About These 2 Medical Device Stocks

    By David Gould - January 23, 2013 | Tickers: BAX, BSX, MDT

    Investing in medical companies is seen as an attractive opportunity due to the rising health needs of baby boomers. Both Baxter and Medtronic are leading producers of medical devices that can target this rapidly growth market. But they have different opportunities and trajectories. Here are some of the strengths behind these two companies:

    Reasons To Be Bullish On Baxter (NYSE: BAX)

    Baxter is a producer of products for treating illnesses more »

  • Will Bad Press Outweigh Strong Earnings for This Medical Device Pioneer?

    By Jordo Bivona - January 19, 2013 | Tickers: BSX, ISRG, QCOR, SYK, VVUS

    Rising earnings estimates and strong third quarter results, including a 28.2% positive earnings surprise, helped Intuitive Surgical (NASDAQ: ISRG) achieve a Zacks #1 Rank (Strong Buy) on Jan. 1. This pioneer of robotic surgery has delivered a positive earnings surprise in each of the last five quarters with an average of 13.7%.

    Looking Ahead

    Zacks expects that a number of procedures currently performed either in an open surgical more »

  • Medical Device Maker Is Too Cheap to Ignore

    By Ted Cooper - January 18, 2013 | Tickers: BSX, MDT, STJ | Editor's Choice

    If uncertainty creates investment opportunity, then there is plenty of opportunity in the healthcare sector. With provisions buried within Obamacare still coming to light and proposed cuts to Medicare making their way through Congress, it is difficult to know which companies will benefit and which will suffer at the hands of the federal government.

    However, some companies are just too cheap to ignore despite the uncertainty. For instance, Medtronic (NYSE: MDTmore »)

  • Medical Device Providers For Your Portfolio

    By Declan Fallon - January 17, 2013 | Tickers: BSX, CNMD, CRY

    There are a number of Medical Device manufacturers trading at deep discount to their highs.  The big name amongst the also-rans is Boston Scientific Corporation (NYSE: BSX), which recently grabbed the headlines after enjoying a consecutive period of buying to take the stock above $5.90, once the end-of-year tax loss selling was complete.  In its heyday, Boston Scientific Corporation traded in the high $40s, but a drop in demand more »

  • Watch these Stocks at JPMorgan's Annual Healthcare Conference

    By John Macris - January 7, 2013 | Tickers: BAX, BSX, CELG, MDT, STJ

    JPMorgan is hosting its 31st Annual Healthcare Conference from Monday, January 7 through Thursday, January 10 in San Francisco, CA. The event is widely recognized as the most significant health care investing event of the year.

    More than 400 companies are scheduled to present at the four-day conference in 2013, including public and private. Not-for-profit companies such as NYU Hospitals Center and Yale-New Haven Health also participate with their own more »

  • Intuitive Surgical Fairly Valued, But Well Worth Buying on Pullback

    By Jordo Bivona - December 24, 2012 | Tickers: BSX, EW, ISRG

    Intuitive Surgical's (NASDAQ: ISRG) da Vinci Surgical System offers surgeons superior 3D HD visualization, enhanced dexterity, greater precision and ergonomic comfort for the optimal performance of MIS. The da Vinci System enables surgeons to perform even complex procedures, such as heart valve and cancer surgery through 1 to 2 centimeter incisions. This breakthrough is allowing hospitals everywhere to extend the benefits of MIS to a broader base of patients more »

  • Page 1 of 3